Search Results 51-60 of 16157 for Epilepsy (Partial Onset)
Mayo Clinic is participating in an invitation-only clinical trial of a new thermoablative treatment for medically refractory focal epilepsy.
The purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizures.
... Focal Lesions in Patients with Medically Refractory Partial Epilepsy ... epilepsy using the Visualase ... epileptic drugs at adequate dose and duration.
A Study to Evaluate MR-guided Focused Ultrasound Ablation Therapy to Treat Focal Epilepsy. ... Subjects should have partial-onset seizures with or without ...
Epilepsy, also known as a seizure disorder, affects people of all races, ethnic backgrounds and ages. Anyone can develop epilepsy.
... seizure onset to suppress the generation of the abnormal seizure discharge; Deep brain stimulation, which delivers controlled pulses to a target in the brain ...
That advanced imaging technology can better detect epileptogenic lesions, such as focal cortical dysplasia, compared with conventional 3-Tesla (3-T) MRI. " ...
... onset of seizures that don't respond to anti-seizure medications. ... onset juvenile myoclonic epilepsy — a relatively common generalized epilepsy.
... focal epilepsy. Participation eligibility ... - Has not had control with at least 2 anti-seizure medicines. - Able to maintain a constant medication for duration ...
Though these are general symptoms, physicians typically separate seizures into two categories, focal or generalized. Both result from abnormal brain ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.